Description

Quinazoline, 1,5,6,7,8,8A-Hexahydro-2-Amino-4-Methyl-, Monoacetate is a high-purity, advanced pharmaceutical intermediate with a distinct, saturated heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of complex active pharmaceutical ingredients (APIs), particularly those targeting central nervous system and cardiovascular pathways. It is primarily sought by research institutions and manufacturers in the pharmaceutical and fine chemical industries for developing novel therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of proprietary drug candidates, especially those with quinazoline-based pharmacophores.
• Neurological Research: Used in the development of compounds for studying and treating neurological disorders.
• Cardiovascular Drug Development: Serves as a building block for molecules targeting hypertension and other cardiovascular conditions.
• Chemical Synthesis: Employed in organic synthesis for constructing complex, saturated nitrogen-containing heterocycles.
• Academic & R&D: Utilized in university and corporate research laboratories for medicinal chemistry programs and structure-activity relationship (SAR) studies.
• Fine Chemical Production: Integrated into multi-step synthesis processes for high-value, low-volume specialty chemicals.

Basic Information

Product Name	Quinazoline, 1,5,6,7,8,8A-Hexahydro-2-Amino-4-Methyl-, Monoacetate
CAS No.	19623-23-5
Molecular Formula	C12H19N3O2
Molecular Weight	237.30 g/mol
Synonyms	1,5,6,7,8,8A-Hexahydro-2-amino-4-methylquinazoline monoacetate; 2-Amino-4-methyl-1,5,6,7,8,8a-hexahydroquinazoline acetate; 4-Methyl-1,5,6,7,8,8a-hexahydro-2-quinazolinamine monoacetate; Hexahydro-2-amino-4-methylquinazoline acetate salt; (1,5,6,7,8,8a-Hexahydro-4-methyl-2-quinazolinyl)amine monoacetate; 19623-23-5; Quinazoline derivative monoacetate salt
EINECS	Contact for details

Quality Control

Our Quinazoline, 1,5,6,7,8,8A-Hexahydro-2-Amino-4-Methyl-, Monoacetate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and production. Certificates of Analysis (COA) detailing specific batch results are available upon request, providing full traceability and compliance data.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture. For long-term storage, consider the use of desiccants.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Unknown Impurity	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.